The enteroviral protease target LSM14A operates outside of P-bodies to augment antiviral innate immunity.

Saved in:
Bibliographic Details
Title: The enteroviral protease target LSM14A operates outside of P-bodies to augment antiviral innate immunity.
Authors: Wacquiez A; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118., Hboub H; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118.; Faculty of Medical Sciences, UM6P Hospitals, Mohammed VI Polytechnic University, Benguerir, 43150, Morocco., Chen DY; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118., Tavares AH; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114., Su CM; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118., De Paz J; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118., Semaan M; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118., Ding Z; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118., Zaia J; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; Boston University Bioinformatics Program, Boston University, Boston, MA 02118., Sethi MK; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118., Lyons SM; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118., Saeed M; Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02118.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 May 12. Date of Electronic Publication: 2026 May 12.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.05.11.723630